Mfge8 and the Role of Apoptotic Cell Clearance in Lung Injury

该提案概述了一项为期五年的职业发展计划，旨在为Atabai博士的职业生涯做好准备。 作为一个肺部医学的学术医生和科学家。Atabai博士有兴趣研究 损伤和修复的潜在机制，特别是与肺相关的机制。急性肺损伤（All） 常见的破坏性炎症，可导致肺纤维化。尽管死亡率很高 率几乎没有有效的治疗方法存在的ALL最近的证据表明， 人ALI和肺纤维化。在导师Dean Sheppard博士的指导下，Atabai博士 MfgeS是一种整合素结合分子，促进凋亡细胞吞噬， 肺损伤Atabai博士发现，缺乏功能性MfgeS的小鼠会发生严重的肺纤维化。 博莱霉素注射后，博来霉素诱导上皮细胞凋亡、炎症和 肺纤维化Atabai博士的假设是，MfgeS通过以下方式调节肺部的损伤和炎症： 促进凋亡细胞清除。测试这一假设的具体目的是：1）确定 MfgeS在肺中凋亡细胞清除中的作用，2）确定MfgeS在调节肺细胞凋亡中的作用， 炎症和肺损伤的严重程度，3）确定磷脂酰丝氨酸残基对肺损伤的作用。 在Mfge S介导的凋亡细胞清除中， vivo. Atabai博士将使用成熟的体外和体内技术来实现这些目标，包括细胞 培养，重组蛋白的产生，免疫组织化学，免疫细胞化学，DNA表达 阵列、实时PCR、ELISA和免疫印迹。Atabai博士的导师Dean Sheppard博士 他是一位富有成效、资金充足的科学家，在整合素生物学、炎症和纤维化方面具有专长， 肺。Sheppard博士在培训成功的学术医生方面有着出色的记录。一个咨询 一个由备受推崇的科学家组成的小组将在获奖期间为Atabai博士提供进一步的指导。一 教学课程培训和参加地方和国家科学会议的详细计划将 成为该计划的最后一部分。Atabai博士拥有UCSF部门的全部承诺， 医学与肺生物中心关于职业发展及获得的一切资源 这是成功完成这项工作所必需的。

This proposal outlines a five-year career development program designed to prepare Dr. Atabai for a career as an academic physician-scientist in pulmonary medicine. Dr. Atabai is interested in studying the mechanisms underlying injury and repair, particularly as they relate to the lung. Acute Lung Injury (All) is a common and devastating inflammatory condition that can lead to pulmonary fibrosis. Despite high mortality rates few effective therapies exist for ALL Recent evidence has implicated a pathogenic role for apoptosis in human ALI and pulmonary fibrosis. Under the guidance of his mentor, Dr. Dean Sheppard, Dr. Atabai has been examining the role of MfgeS, an integrin binding molecule that facilitates apoptotic cell engulfment, in lung injury. Dr. Atabai has found that mice lacking functional MfgeS develop exaggerated pulmonary fibrosis after intratracheal bleomycin administration. Bleomycin induces epithelial cell apoptosis, inflammation and pulmonary fibrosis. Dr. Atabai's hypothesis is that MfgeS modulates injury and inflammation in the lung by facilitating apoptotic cell clearance. The specific aims designed to test this hypothesis are 1) determining the role of MfgeS in apoptotic cell clearance in the lung, 2) determining the role of MfgeS in regulating inflammation and the severity of lung injury, 3) determining the role of phosphatidylserine residues on apoptotic cells and the avps and av(35 integrins on phagocytes in MfgeS-mediated apoptotic cell clearance in vivo. Dr. Atabai will use well-established in vitro and in vivo techniques to achieve these aims including cell culture, generation of recombinant proteins, immunohistochemistry, immunocytochemistry, DNA expression arrays, Real-Time PCR, ELISA, and immunoblotting. Dr. Atabai's mentor, Dr. Dean Sheppard, is a productive and well-funded scientist with expertise in integrin biology and inflammation and fibrosis in the lung. Dr. Sheppard has an outstanding track record of training successful academic physicians. An advisory panel of highly regarded scientists will provide further guidance to Dr. Atabai for the duration of the award. A detailed program of didactic course training and participation in local and national scientific conferenceswill be the final component of the program. Dr. Atabai has the full commitment of the UCSF Department of Medicine and the Lung Biology Center with regard to career development and access to all the resources necessary for the successful completion of this work.